Population/Method of Scaling | AUC_pred (ng⋅h/ml) | Percent Difference in Disease Impact (AUCR_pred) from EFLV Method | |
---|---|---|---|
Healthy | 1 | — a | |
Cirrhosis CP-A | CS | 2.2 | 40% |
CS + SA | 1.6 | 2% | |
EFLV | 1.6 | — | |
Cirrhosis CP-B | CS | 1.6 | 8% |
CS + SA | 1.8 | 1% | |
EFLV | 1.8 | — | |
Cirrhosis CP-C | CS | 37 | 12% |
CS + SA | 51 | 12% | |
EFLV | 48 | — |
pred, predicted value from the simulation.
↵a Not applicable.